Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015–2021 cohort study

Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015–2021 cohort study

Background The introduction of immune checkpoint inhibitors (ICIs) has modified treatment modalities for patients with lung cancer, offering new alternatives for treatment. Despite improved survival benefits, ICIs may cause side effects impacting patients’ quality of life (QoL). We aim to study the...

Full description

Saved in:
Bibliographic Details
Main Authors: Manuela Quaresma, Bernard Rachet, Geertruida H De Bock, Clémence Leyrat, Willemijn J Maas, Erick Suazo-Zepeda, Ananya Malhotra, Petra C Vinke, Jeroen T J.N Hiltermann
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/2/e098062.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items